US 11655275
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
granted A61KA61K35/42A61K35/545
Quick answer
US patent 11655275 (Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene) held by Sangamo Therapeutics, Inc. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K35/42, A61K35/545, A61K38/00